Franklin Templeton Mutual Fund increased its stake in Jubilant Ingrevia from 1.73% to 1.82%, raising its shareholding from 2,756,134 to 2,892,594 shares. The shares are valued at ₹736.30 apiece.
A global integrated provider of life science products and innovative solutions, Jubilant Ingrevia serves pharmaceutical, nutrition, agrochemical, consumer, and industrial customers worldwide. The company manufactures customized products designed to be cost-effective and fully compliant with stringent quality standards. Its vertically integrated approach to developing specialized solutions for diverse industry verticals distinguishes it in the competitive basic materials sector.
Indian arm of Franklin Templeton Investments, a global AMC with over USD 1.5 trillion in assets worldwide. Manages over Rs 1.2 lakh crore in India. Navigated a significant setback when six debt schemes were wound up in April 2020 due to illiquid credit exposure, with full investor capital recovered by 2022. Equity franchise led by CIO Anand Radhakrishnan has maintained consistent performance through the volatility.
